2
|
Kasana S, Din J, Maret W. Genetic causes and gene–nutrient interactions in mammalian zinc deficiencies: acrodermatitis enteropathica and transient neonatal zinc deficiency as examples. J Trace Elem Med Biol 2015; 29:47-62. [PMID: 25468189 DOI: 10.1016/j.jtemb.2014.10.003] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/04/2014] [Revised: 10/14/2014] [Accepted: 10/16/2014] [Indexed: 12/31/2022]
Abstract
Discovering genetic causes of zinc deficiency has been a remarkable scientific journey. It started with the description of a rare skin disease, its treatment with various agents, the successful therapy with zinc, and the identification of mutations in a zinc transporter causing the disease. The journey continues with defining the molecular and cellular pathways that lead to the symptoms caused by zinc deficiency. Remarkably, at least two zinc transporters from separate protein families are now known to be involved in the genetics of zinc deficiency. One is ZIP4, which is involved in intestinal zinc uptake. Its mutations can cause acrodermatitis enteropathica (AE) with autosomal recessive inheritance. The other one is ZnT2, the transporter responsible for supplying human milk with zinc. Mutations in this transporter cause transient neonatal zinc deficiency (TNZD) with symptoms similar to AE but with autosomal dominant inheritance. The two diseases can be distinguished in affected infants. AE is fatal if zinc is not supplied to the infant after weaning, whereas TNZD is a genetic defect of the mother limiting the supply of zinc in the milk, and therefore the infant usually will obtain enough zinc once weaned. Although these diseases are relatively rare, the full functional consequences of the numerous mutations in ZIP4 and ZnT2 and their interactions with dietary zinc are not known. In particular, it remains unexplored whether some mutations cause milder disease phenotypes or increase the risk for other diseases if dietary zinc requirements are not met or exceeded. Thus, it is not known whether widespread zinc deficiency in human populations is based primarily on a nutritional deficiency or determined by genetic factors as well. This consideration becomes even more significant with regard to mutations in the other 22 human zinc transporters, where associations with a range of diseases, including diabetes, heart disease, and mental illnesses have been observed. Therefore, clinical tests for genetic disorders of zinc metabolism need to be developed.
Collapse
|
3
|
Mouat MF, Kolli K, Orlando R, Hargrove JL, Grider A. The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study. Nutr J 2005; 4:11. [PMID: 15748282 PMCID: PMC555539 DOI: 10.1186/1475-2891-4-11] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2005] [Accepted: 03/04/2005] [Indexed: 12/02/2022] Open
Abstract
Background High fruit and vegetable intake is known to reduce the risk of colon cancer. To improve understanding of this phenomenon the action of different phytochemicals on colon cells has been examined. One such compound is quercetin that belongs to the group known as flavonoids. The purpose of this study was to determine the influence of quercetin on the proteome of the SW480 human colon adenocarcinoma cell line, specifically to identify proteins that could be the molecular targets of quercetin in its amelioration of the progression of colon cancer. To this end, two-dimensional gel electrophoresis and mass spectrometry were used to identify proteins that underwent a change in expression following treatment of the cells with 20 μM quercetin. This could elucidate how quercetin may reduce the progression of colon cancer. Results Quercetin treatment of the SW480 human colon cancer cells was found to result in the decreased expression of three proteins and the increased expression of one protein. The identified proteins with decreased expression were type II cytoskeletal 8 keratin and NADH dehydrogenase Fe-S protein 3. The other protein with decreased expression was not identified. The protein with increased expression belonged to the annexin family. Conclusion Several proteins were determined to have altered expression following treatment with quercetin. Such changes in the levels of these particular proteins could underlie the chemo-protective action of quercetin towards colon cancer.
Collapse
Affiliation(s)
- Michael F Mouat
- Department of Foods and Nutrition, University of Georgia, Athens, Georgia 30602, USA
| | - Kumar Kolli
- Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602, USA
| | - Ronald Orlando
- Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602, USA
| | - James L Hargrove
- Department of Foods and Nutrition, University of Georgia, Athens, Georgia 30602, USA
| | - Arthur Grider
- Department of Foods and Nutrition, University of Georgia, Athens, Georgia 30602, USA
| |
Collapse
|
7
|
Wang K, Pugh EW, Griffen S, Doheny KF, Mostafa WZ, al-Aboosi MM, el-Shanti H, Gitschier J. Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3. Am J Hum Genet 2001; 68:1055-60. [PMID: 11254458 PMCID: PMC1275625 DOI: 10.1086/319514] [Citation(s) in RCA: 80] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2000] [Accepted: 02/13/2001] [Indexed: 11/03/2022] Open
Abstract
Acrodermatitis enteropathica (AE) is a rare autosomal recessive pediatric disease characterized by dermatitis, diarrhea, alopecia, and growth failure. The disease results from insufficient uptake of zinc by the intestine and can be fatal unless the diet is supplemented with zinc. To map the gene responsible for AE, a genomewide screen was performed on 17 individuals, including 4 affected individuals, in a consanguineous Jordanian family. Three markers-D8S373, D10S212, and D6S1021-had a pattern consistent with tight linkage to a recessive disease: one allele in the affected sibs and multiple alleles in unaffected sibs and parents. Two-point parametric linkage analysis using FASTLINK identified one region, D8S373, with a maximum LOD score >1.5 (1.94 at D8S373: recombination fraction.001). Twelve additional markers flanking D8S373 were used to genotype the extended family, to fine-map the AE gene. All five affected individuals-including one who was not genotyped in the genomewide screen-were found to be homozygous for a common haplotype, spanning approximately 3.5 cM, defined by markers D8S1713 and D8S2334 on chromosomal region 8q24.3. To support these mapping data, seven consanguineous Egyptian families with eight patients with AE were genotyped using these markers, and six patients from five families were found to be homozygous in this region. Multipoint analysis with all consanguineous families, by Mapmaker/Homoz, resulted in a maximum LOD score of 3.89 between D8S1713 and D8S373. Sliding three-point analysis resulted in a maximum LOD score of 5.16 between markers D8S1727 and D8S1744.
Collapse
Affiliation(s)
- Kun Wang
- Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco; Center for Inherited Disease Research, Johns Hopkins University, Baltimore; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo; and Departments of Dermatology and Pediatrics and Medical Genetics, Jordan University of Science and Technology, Irbid, Jordan
| | - Elizabeth W. Pugh
- Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco; Center for Inherited Disease Research, Johns Hopkins University, Baltimore; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo; and Departments of Dermatology and Pediatrics and Medical Genetics, Jordan University of Science and Technology, Irbid, Jordan
| | - Shari Griffen
- Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco; Center for Inherited Disease Research, Johns Hopkins University, Baltimore; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo; and Departments of Dermatology and Pediatrics and Medical Genetics, Jordan University of Science and Technology, Irbid, Jordan
| | - Kimberly F. Doheny
- Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco; Center for Inherited Disease Research, Johns Hopkins University, Baltimore; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo; and Departments of Dermatology and Pediatrics and Medical Genetics, Jordan University of Science and Technology, Irbid, Jordan
| | - Wedad Z. Mostafa
- Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco; Center for Inherited Disease Research, Johns Hopkins University, Baltimore; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo; and Departments of Dermatology and Pediatrics and Medical Genetics, Jordan University of Science and Technology, Irbid, Jordan
| | - Mustafa M. al-Aboosi
- Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco; Center for Inherited Disease Research, Johns Hopkins University, Baltimore; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo; and Departments of Dermatology and Pediatrics and Medical Genetics, Jordan University of Science and Technology, Irbid, Jordan
| | - Hatem el-Shanti
- Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco; Center for Inherited Disease Research, Johns Hopkins University, Baltimore; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo; and Departments of Dermatology and Pediatrics and Medical Genetics, Jordan University of Science and Technology, Irbid, Jordan
| | - Jane Gitschier
- Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco; Center for Inherited Disease Research, Johns Hopkins University, Baltimore; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo; and Departments of Dermatology and Pediatrics and Medical Genetics, Jordan University of Science and Technology, Irbid, Jordan
| |
Collapse
|
8
|
Murgia C, Vespignani I, Cerase J, Nobili F, Perozzi G. Cloning, expression, and vesicular localization of zinc transporter Dri 27/ZnT4 in intestinal tissue and cells. Am J Physiol Gastrointest Liver Physiol 1999; 277:G1231-9. [PMID: 10600821 DOI: 10.1152/ajpgi.1999.277.6.g1231] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/14/2023]
Abstract
We have identified the Dri 27 cDNA on the basis of its upregulated expression during rat intestinal development. It encodes a hydrophobic protein of 430 amino acids that shares significant homology with members of the mammalian zinc transporter family ZnT. The murine homologue of Dri 27 (named ZnT4) was recently associated with the mouse mutation “lethal milk.” The primary sequence of Dri 27/ZnT4 displays features characteristic of polytopic membrane proteins. In this paper, we show that Dri 27/ZnT4 is localized in the membrane of intracellular vesicles, the majority of which concentrate in the basal cytoplasmic region of polarized enterocytes. A Dri 27/ZnT4 myc-tagged construct, transiently transfected in intestinal Caco-2 cells, partially colocalizes with the transferrin receptor and with the β-subunits of the clathrin adaptor complexes AP-1 and AP-2 in a subpopulation of endosomal vesicles. By subcloning distinct portions of the protein in frame with glutathione- S-transferase, we also provide experimental evidence of their function as zinc-binding and protein-protein-interaction domains.
Collapse
Affiliation(s)
- C Murgia
- Istituto Nazionale della Nutrizione, 00178 Rome, Italy
| | | | | | | | | |
Collapse
|
9
|
Muga SJ, Grider A. Partial characterization of a human zinc-deficiency syndrome by differential display. Biol Trace Elem Res 1999; 68:1-12. [PMID: 10208652 DOI: 10.1007/bf02784392] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
The effect of the acrodermatitis enteropathica mutation (AE) on gene expression was investigated using differential display. Two differentially expressed cDNAs were partially characterized. The NA8 cDNA (HT11A anchor and HAP 8 random primer pair) was expressed in greater quantity in normal fibroblasts, was 249 bp, and hybridized to three mRNA species (2 kb, 1 kb, 0.8 kb). Northern blot analysis indicated that the relative amounts of the AE mRNA species were reduced by 73%, 75%, and 52%, respectively. The cDNA sequence exhibited 92-93% homology to the human cytochrome oxidase subunit II, as analyzed through the GenBank database. The AEG4 cDNA species (HT11G anchor and HAP 4 random, primer pair) was expressed in greater quantity in AE fibroblasts, was 197 bp, and hybridized to two mRNA species (9 kb, 4 kb). Northern blot analysis indicated that the 9-kb mRNA species was present equally in AE and normal cells, but the 4-kb mRNA species was only present in the AE fibroblasts. The cDNA sequence exhibited 92% homology to LINE1 human retrotransposons, as analyzed through the GenBank database. The functional relationship between the mutation and the reduced expression of cytochrome oxidase subunit II is unknown at this time and needs to be addressed. The increased expression of the LINE1 element in AE fibroblasts may be indicative of an insertion mutation affecting the mRNA of a protein involved in zinc transport, a prospect which requires further investigation.
Collapse
Affiliation(s)
- S J Muga
- The University of Texas M.D. Anderson Cancer Research Center, Smithville 78757, USA
| | | |
Collapse
|